EMA Withdrawn: Possia (ticagrelor) — AstraZeneca AB

View source ↗

Summary

Possia (ticagrelor) has been withdrawn from market authorization by AstraZeneca AB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Peripheral Vascular Diseases

Drugs mentioned

• Possia (ticagrelor)

Snippet

Status: Withdrawn. Therapeutic area: Peripheral Vascular Diseases;Acute Coronary Syndrome. MAH: AstraZeneca AB. Decision date: 24/10/2012